Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Collagen hydrolysate + rosehip extract is a nutraceutical combination used primarily for the management of joint pain and inflammation associated with osteoarthritis. Collagen hydrolysate, a form of collagen broken down into smaller peptides, serves as a building block for cartilage regeneration and supports joint mobility. Rosehip extract, derived from the fruit of the *Rosa canina* plant, contains bioactive compounds such as polyphenols, anthocyanins, and galactolipids (e.g., GOPO) that exhibit anti-inflammatory and antioxidant properties. Studies suggest a synergistic effect where the combination enhances collagen synthesis more effectively than collagen hydrolysate alone. It is typically administered orally as a sachet and is marketed as a dietary supplement rather than a traditional pharmaceutical drug.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on collagen hydrolysate + rosehip extract.